The Effects of Hepatogomax Enteral Formula on Systemic Inflammation, Caecum Short-Chain Fatty Acid Levels, and Liver Histopathology in Thioacetamide-Induced Rats
Table 1
Body weight of rats.
Body weight (g)
Means ± SD
1
2
Means ± SD
Initial
Before TAA-induced
Before intervention
After intervention
ΔBB1
ΔBB2
K1
182 ± 3.46
189.17 ± 2.86
203.5 ± 2.43
232.5 ± 3.51
<0.001
<0.001
14.33 ± 1.03a,b
29 ± 1.67a,b
K2
179.5 ± 4.59
186.17 ± 4.36
191.83 ± 4.79
201 ± 6.1
<0.001
<0.001
5.67 ± 0.82a
9.17 ± 1.72a,b
K3
180.33 ± 2.94
187.67 ± 2.58
194.83 ± 3.19
223.83 ± 3.49
<0.001
<0.001
7.17 ± 2.04a
29 ± 1.79a
P1
181 ± 3.35
188.5 ± 3.02
194.67 ± 3.78
211.83 ± 4.96
<0.001
<0.001
6.17 ± 0.98a
17.17 ± 1.83a,b
P2
178.17 ± 3.31
185.33 ± 3.72
191.67 ± 3.93
217.67 ± 4.32
<0.001
<0.001
6.33 ± 0.82a
26 ± 1.10a,b
P3
179.5 ± 3.78
186.67 ± 3.44
192.67 ± 3.61
221.17 ± 3.82
<0.001
<0.001
6.00 ± 0.63a
28.5 ± 0.55b
3
0.003
<0.001
1Paired t-test, 1 = value before TAA-induced and before intervention; 2 = value before and after intervention; significant difference ( < 0.05); ΔBB1 = BW change before TAA-induced and before intervention; ΔBB2 = BW before and after intervention; 2Kruskal–Wallis test; significant difference ( < 0.05); asignificant difference against the control group (Mann–Whitney test); bsignificant difference against the intervention group (Mann–Whitney test).